94 related articles for article (PubMed ID: 20228853)
21. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
22. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF.
Rüetschi U; Zetterberg H; Podust VN; Gottfries J; Li S; Hviid Simonsen A; McGuire J; Karlsson M; Rymo L; Davies H; Minthon L; Blennow K
Exp Neurol; 2005 Dec; 196(2):273-81. PubMed ID: 16154129
[TBL] [Abstract][Full Text] [Related]
23. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
24. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
25. Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.
Miguet L; Bogumil R; Decloquement P; Herbrecht R; Potier N; Mauvieux L; Van Dorsselaer A
J Proteome Res; 2006 Sep; 5(9):2258-69. PubMed ID: 16944938
[TBL] [Abstract][Full Text] [Related]
26. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
28. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
29. Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum.
Bons JA; Drent M; Bouwman FG; Mariman EC; van Dieijen-Visser MP; Wodzig WK
Respir Med; 2007 Aug; 101(8):1687-95. PubMed ID: 17446058
[TBL] [Abstract][Full Text] [Related]
30. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
31. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
32. [Screening urine markers of renal cell carcinoma using SELDI-TOF-MS].
Wu DL; Wang WJ; Guan M; Jin SB; Jin CR; Zhang YF
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(13):1092-5. PubMed ID: 15312509
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic serum proteomic analysis in patients with active tuberculosis.
Zhang J; Wu X; Shi L; Liang Y; Xie Z; Yang Y; Li Z; Liu C; Yang F
Clin Chim Acta; 2012 May; 413(9-10):883-7. PubMed ID: 22330877
[TBL] [Abstract][Full Text] [Related]
34. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
35. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
[TBL] [Abstract][Full Text] [Related]
36. [Detection of tissue protein biomarkers by surface enhanced laser desorption/ionization-time of flight-mass spectrometry in patients with mycosis fungoides].
Liu J; Zheng YH; Zhou YF; Zhang JZ; Wang BX
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):100-4. PubMed ID: 19489271
[TBL] [Abstract][Full Text] [Related]
37. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
[TBL] [Abstract][Full Text] [Related]
38. [The contribution for the diagnosis of the tumor-like polypoid lesions of the gallbladder by SELDI-TOF-MS].
Luan FM; Ge CL; Ma N; Li YZ; Hu CJ; Li N
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):525-7. PubMed ID: 18785564
[TBL] [Abstract][Full Text] [Related]
39. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
40. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis.
Zhang G; Zhou B; Zheng Y; Feng K; Rao L; Zhang J; Xin J; Zhang B; Zhang L
Int J Cardiol; 2009 Jan; 131(2):225-33. PubMed ID: 18180059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]